Dr. Ali Khaki is a Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine and a genitourinary medical oncologist at Stanford Health Care. He specializes in Hematology and Oncology with a subspecialty focus on kidney, bladder (urothelial), prostate, and testicular cancers. In addition to leading inpatient oncology services, he advances clinical care through research on novel therapies for genitourinary cancers, particularly urothelial carcinoma. Dr. Khaki completed his residency in Internal Medicine at the University of California, San Francisco, followed by fellowships in Hematology and Medical Oncology at the University of Washington and Fred Hutchinson Cancer Research Center. He is board certified in Hematology and Medical Oncology. His research centers on immunotherapy, healthcare utilization, and outcomes in urothelial cancer, and he has authored numerous publications on immunotherapy, COVID-19 in cancer patients, and prognostic models in urothelial carcinoma. He has been recognized with honors from the American Society of Clinical Oncology and the Bladder Cancer Advocacy Network for his contributions to patient care and cancer research.
Stanford University School of Medicine
2021 – present
Medical School
Residency
Fellowship
2017 – 2020